Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Melanoma

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Recruiting

IL-17 Blockade to Decrease irAEs (REPLAY)

NCT07237594

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Recruiting

Cryoablation+Ipilimumab+Nivolumab in Melanoma

NCT05779423

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

NCT07564570

Conditions: Behavior, Melanoma, Metastatic Melanoma, +12 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany

View Trial Details

Recruiting

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

NCT07504796

Conditions: Advanced Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: NYU Langone Health New York, United States

View Trial Details

Recruiting

Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases

NCT05026983

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

NCT04693377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1

NCT05856565

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Besancon University Hospital Besançon, Bourgogne-Franche-Comté, France

Brest University Hospital Brest, Finistère, France

Angers University Hospital Angers, Maine-et-Loire, France

Blois Hospital site Blois, France

View all 20 locations

View Trial Details

Recruiting

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

NCT05913388

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +16 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

NCT07112170

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details